Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Moriarty

Showing results (401-410 of 427) with videos related to

Pageof 43
Sort By:
American Heart Journal|March 1, 2014
Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registryEmily C O'Brien, Matthew T Roe, Elizabeth S Fraulo, et al.
European Heart Journal|January 13, 2022
Apolipoprotein C-III reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular riskJean-Claude Tardif, Ewa Karwatowska-Prokopczuk, Eric St Amour, et al.
Circulation|September 3, 2019
Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary SyndromesMatthew T Roe, Qian H Li, Deepak L Bhatt, et al.
Journal of the American College of Cardiology|September 4, 2024
Triglyceride Levels, Alirocumab Treatment, and Cardiovascular Outcomes After an Acute Coronary SyndromeDoron Zahger, Gregory G Schwartz, Weiming Du, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|January 14, 2025
Percutaneous Mechanical Aspiration for Infective Endocarditis: Proceedings From an Inaugural Multidisciplinary Summit and Comprehensive ReviewLucas X Marinacci, Sanjum S Sethi, Molly L Paras, et al.
Journal of the American College of Cardiology|September 2, 2017
Optimizing Cholesterol Treatment in Patients With Muscle ComplaintsRobert S Rosenson, Steven Baker, Maciej Banach, et al.
The Journal of Clinical Investigation|January 5, 2012
Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatinA Phillip Owens, Freda H Passam, Silvio Antoniak, et al.
Journal of the American College of Radiology : JACR|April 1, 2015
ACR Appropriateness Criteria Imaging in the Diagnosis of Thoracic Outlet SyndromeJohn M Moriarty, Dennis F Bandyk, Daniel F Broderick, et al.
European Heart Journal|October 14, 2020
Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trialMichael Szarek, Vera A Bittner, Philip Aylward, et al.
European Heart Journal. Acute Cardiovascular Care|February 13, 2024
Modelling costs of interventional pulmonary embolism treatment: implications of US trends for a European healthcare systemKatharina Mohr, Brent Keeling, Klaus Kaier, et al.
Pageof 43

Showing results (401-410 of 427) with videos related to

Sort By:
Pageof 43
American Heart Journal|March 1, 2014
Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registryEmily C O'Brien, Matthew T Roe, Elizabeth S Fraulo, et al.
European Heart Journal|January 13, 2022
Apolipoprotein C-III reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular riskJean-Claude Tardif, Ewa Karwatowska-Prokopczuk, Eric St Amour, et al.
Circulation|September 3, 2019
Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary SyndromesMatthew T Roe, Qian H Li, Deepak L Bhatt, et al.
Journal of the American College of Cardiology|September 4, 2024
Triglyceride Levels, Alirocumab Treatment, and Cardiovascular Outcomes After an Acute Coronary SyndromeDoron Zahger, Gregory G Schwartz, Weiming Du, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|January 14, 2025
Percutaneous Mechanical Aspiration for Infective Endocarditis: Proceedings From an Inaugural Multidisciplinary Summit and Comprehensive ReviewLucas X Marinacci, Sanjum S Sethi, Molly L Paras, et al.
Journal of the American College of Cardiology|September 2, 2017
Optimizing Cholesterol Treatment in Patients With Muscle ComplaintsRobert S Rosenson, Steven Baker, Maciej Banach, et al.
The Journal of Clinical Investigation|January 5, 2012
Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatinA Phillip Owens, Freda H Passam, Silvio Antoniak, et al.
Journal of the American College of Radiology : JACR|April 1, 2015
ACR Appropriateness Criteria Imaging in the Diagnosis of Thoracic Outlet SyndromeJohn M Moriarty, Dennis F Bandyk, Daniel F Broderick, et al.
European Heart Journal|October 14, 2020
Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trialMichael Szarek, Vera A Bittner, Philip Aylward, et al.
European Heart Journal. Acute Cardiovascular Care|February 13, 2024
Modelling costs of interventional pulmonary embolism treatment: implications of US trends for a European healthcare systemKatharina Mohr, Brent Keeling, Klaus Kaier, et al.
Pageof 43